Global Bartonellosis Market
Healthcare Services

CMP testing market forecast through 2030 with growth insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Comprehensive Metabolic Panel (CMP) Testing Market In 2026, And How Will Its Value Evolve By 2030?

The comprehensive metabolic panel (cmp) testing market size has experienced strong expansion in recent years. This market is set to grow from $18.34 billion in 2025 to $19.94 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. Historically, this growth can be attributed to the rising prevalence of chronic diseases, the expansion of diagnostic laboratory networks, increased adoption of blood chemistry testing, better access to routine health screening, and a growing awareness of preventive diagnostics.

The comprehensive metabolic panel (cmp) testing market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $28.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. The expansion foreseen in this period can be ascribed to a surging need for swift diagnostic options, the proliferation of decentralized testing approaches, increased adoption of integrated laboratory automation, a heightened emphasis on population health screening, and escalating investments in diagnostic infrastructure. Prominent developments during the forecast horizon involve the increasing integration of automated clinical chemistry analyzers, a rising call for routine metabolic screening, enhanced incorporation of laboratory information systems, the broadening of point-of-care cmp testing, and a stronger focus on identifying diseases early.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/comprehensive-metabolic-panel-cmp-testing-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Comprehensive Metabolic Panel (CMP) Testing Market?

The anticipated expansion of the comprehensive metabolic panel (CMP) testing market is driven by the rising incidence of cardiovascular diseases and diabetes. Conditions affecting the heart or blood vessels, known as cardiovascular disorders, are associated with atherosclerosis, characterized by the accumulation of fatty deposits within arteries. Diabetes arises when blood glucose concentrations become excessively elevated. Comprehensive metabolic panel (CMP) blood tests are instrumental in identifying glucose levels. Consequently, the growing occurrence of diabetes and cardiovascular diseases necessitates diagnosis via blood tests like the CMP blood test, thereby fostering market expansion. As an illustration, data from October 2024 provided by the Centers for Disease Control and Prevention, a US government body, revealed that in 2023, cardiovascular disease was responsible for 919,032 fatalities, representing one in every three deaths. Coronary heart disease continued to be the most common type of heart disease, and remarkably, approximately one in six cardiovascular disease-related deaths affected individuals under the age of 65 years. This clearly indicates that the rising prevalence of cardiovascular diseases and diabetes is fueling the growth of the comprehensive metabolic panel (CMP) testing market.

How Is The Comprehensive Metabolic Panel (CMP) Testing Market Broken Down By Segment Categories?

The comprehensive metabolic panel (cmp) testing market covered in this report is segmented –

1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases

2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose

3) By End User: Laboratories, Point Of Care (PoC)

Subsegments:

1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis

2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease

3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes

4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases

Which Trends Are Shaping The Comprehensive Metabolic Panel (CMP) Testing Market?

Leading companies operating in the comprehensive metabolic panel (CMP) testing market are concentrating on developing sophisticated solutions, such as integrated clinical chemistry and immunoassay analyzers, to deliver more rapid, streamlined, and consolidated CMP testing workflows. These integrated clinical chemistry and immunoassay analyzers are unified systems that perform both chemistry and immunoassay tests on a single platform, enabling laboratories to expedite testing, minimize manual procedures, and consolidate CMP and related panels for more efficient processes and quicker results. For instance, in July 2023, Siemens Healthineers AG, a Germany-based medical technology company, introduced the Atellica CI Analyzer, an integrated clinical chemistry and immunoassay system aimed at laboratories seeking compact, high-quality comprehensive metabolic panel workflows. The Atellica CI Analyzer is a modular, random-access platform that combines chemistry and immunoassay functionalities within a single footprint, supports an extensive and growing assay menu, and utilizes digitized workflows and advanced reporting to enhance turnaround times and sample traceability. Its features include automated sample management and priority testing, built-in diagnostics and IT connectivity for LIS/HIS integration, and an assay development pipeline that permits labs to consolidate CMP testing and associated panels on one system, leading to faster clinician decision-making and less hands-on time compared to directing samples across multiple instruments.

Which Players Are Present In The Comprehensive Metabolic Panel (CMP) Testing Market Space?

Major companies operating in the comprehensive metabolic panel (cmp) testing market are Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC

Get The Full Comprehensive Metabolic Panel (CMP) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/comprehensive-metabolic-panel-cmp-testing-global-market-report

Which Region Dominates The Comprehensive Metabolic Panel (CMP) Testing Market By Market Share?

North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Comprehensive Metabolic Panel (CMP) Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/comprehensive-metabolic-panel-cmp-testing-global-market-report

Browse Through More Reports Similar to the Global Comprehensive Metabolic Panel (CMP) Testing Market 2026, By The Business Research Company

Fully Automatic Biochemistry Analyzer Market Report 2026

https://www.thebusinessresearchcompany.com/report/fully-automatic-biochemistry-analyzer-global-market-report

Lipid Panel Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Biopharmaceutical Cmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *